ClinicalTrials.gg
Not yet recruitingNCT07738133Updated Oct 9, 2026

Mechanisms Underlying Late-Life Prolonged Grief Disorder

An interventional study of Iyengar Yoga and Health Education Control in Prolonged Grief Disorder, sponsored by Medical College of Wisconsin. Not yet recruiting at 1 site in United States. Open to participants aged 40 Years to 89 Years. Per ClinicalTrials.gov, last updated 2026-10-09.

Sponsored by Medical College of Wisconsin · Not applicable, Interventional, and Other

How we know

Updated Oct 9, 2026Primary outcomes revisedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
126
Allocation
Randomized
Ages
40 Years to 89 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Prolonged Grief Disorder with a site in United States — 4 open to participants now, 5 under way, none of them phase 3. Prolonged Grief Disorder · United States.

Planned enrollment
4th of 14
126 · median 42
Started
2027
the only one that year
No phase
10 of 15
3 open now
Registered
15th of 15
by date
Lead sponsor
2 of 15
Medical College of Wisconsin

Among the 15 studies in Prolonged Grief Disorder with a site in United States, this one is the 4th largest by planned enrollment of the 14 interventional ones that give a count, is the only one that started in 2027, is one of 10 with no phase, and was the 15th registered.

Prolonged Grief Disorder

40 studies on the registry are indexed under Prolonged Grief Disorder; 14 are open to participants now.

Browse Prolonged Grief Disorder studies →

Open to participants now

4 of the 15 studies in Prolonged Grief Disorder with a site in United States are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 9 Prolonged Grief Disorder studies recruiting now, 7 set no upper age limit and 2 stop at 75 or younger; none take children under 18; 4 take healthy volunteers.

This study: 40 Years to 89 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Prolonged Grief Disorder with a site in United States, or all of them as a file.
02

Study summary

After losing a loved one, most successfully navigate acute grief and adapt to the loss within about 1 year, but in about 10%, prolonged grief disorder (PGD) ensues. This study is anticipated to provide novel evidence regarding the neurobiological mechanisms of PGD in older adults. The biological alterations identified here could provide targets to elucidate how currently available therapies work and inform novel mechanism-based interventions for treating late-life PGD.

Read the detailed description

The objectives of this study are to (1) identify functional brain network features that differentiate PGD from integrated grief, and (2) conduct a mechanistic study in older adults with PGD to test whether exposure to 10-weeks of IY and HE modulate brain network targets and clarify how network changes relate to clinical response.

03

Conditions studied

  • Prolonged Grief Disorder

Keywords

  • Grief
  • Yoga
  • Health Education
04

Who can participate

Ages eligible
40 Years to 89 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male or female greater than or equal to 40 years of age
  • Bereavement >6 months
  • Score greater than or equal to 25 on the Inventory of Complicated Grief (ICG)
  • Presence of PGD (subsyndromal and syndromal)
  • Adequate visual and auditory acuity

Exclusion criteria

Exclusion Criteria:

  • Delirium/unstable medical conditions
  • Lifetime history of neurological illnesses: seizures, stroke, dementia of any -etiology, severe head injury, brain tumor or surgery
  • Serious back, joint or neck injuries within the past 3 months
  • Currently practicing yoga
  • Gross structural abnormalities on T1-weighted images
  • Lifetime history of the following psychiatric disorders: bipolar or psychotic -disorders, including psychotic depression
  • Current alcohol/drug abuse or dependence
  • Magnetic resonance imaging (MRI)
  • Acute suicidality
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
126 participants (estimated)

Study arms

  • Experimental
    Yoga

    Participants will engage in 10 weekly IY classes

    Behavioral: Iyengar Yoga

  • Active comparator
    Socialization Control

    Participants will engage in 10 weekly socialization control group sessions

    Behavioral: Health Education Control

  • Other
    Waitlist Control

    Waitlist Control

    Other: Waitlist Control to Crossover

Interventions

  • BehavioralIyengar Yoga

    Participants will engage in 10 weekly IY classes

  • BehavioralHealth Education Control

    Participants will engage in 10 weekly socialization control group sessions

  • OtherWaitlist Control to Crossover

    Upon Step 1 study completion (week 10), participants in this group who continue to meet PGD criteria on the SCIP will enter Step 2 phase

06

What researchers measure

Primary outcomes

  1. Score on the Prolonged Grief 13-Revised (PG-13-R) scale

    The investigators will measure change in the PG-13-R score from baseline to end of study. The PG-13-R scores range from 10 - 50 (higher scores indicate more severe grief symptoms).

    Time frame: Baseline through study completion, up to 10 weeks

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — IPD cannot be shared due to confidentiality concerns for our patient population.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2027; primary completion for Jan 2031, 48 months later.

Of 27 interventional studies with no phase under Prolonged Grief Disorder, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 57. This study's planned 48 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 23, 2026
First posted
Jul 31, 2026
StartEst.
Jan 2027
Primary completionEst.
Jan 2031
CompletionEst.
Jun 2031
Last update
Oct 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary outcomes
1 description edited
What changed in the outcomes
  • DescriptionScore on the Prolonged Grief 13-Revised (PG-13-R) scale: how it is measured was reworded
Oct 9, 2026
Show all 1 update
  1. Oct 9, 2026
    Primary outcomes 1 description edited
    What changed in the outcomes
    • DescriptionScore on the Prolonged Grief 13-Revised (PG-13-R) scale: how it is measured was reworded

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07738133
Responsible party
Joseph Goveas (Professor, Department of Psychiatry and Behavioral Medicine, Medical College of Wisconsin) — Principal investigator
First posted
Jul 31, 2026
Start date
Jan 2027 (estimated)
Primary completion
Jan 2031 (estimated)
Completion
Jun 2031 (estimated)
Last update
Oct 9, 2026

Study contacts

Joseph Goveas, MD
Contact
jgoveas@mcw.edu
414-955-8970
Keri Hainsworth, PhD
Contact
khainsworth@mcw.edu
414-852-9046

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion